PRTODAY / NewswireToday Free press release distribution service network

More news: Health/Surgery
Written by / Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Award Commends Augurix for its Unique Simtomax Test for Celiac Disease - The 2010 Frost & Sullivan European Product Differentiation Excellence Award in Point of Care Testing is presented to Augurix
Frost & Sullivan Award Commends Augurix for its Unique Simtomax Test for Celiac Disease

 

NewswireToday - /newswire/ - London, United Kingdom, 2011/03/08 - The 2010 Frost & Sullivan European Product Differentiation Excellence Award in Point of Care Testing is presented to Augurix.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

The company is honored for developing the Simtomax test - the only known point of care test for Celiac disease - that can be performed by even untrained personnel to arrive at an instant diagnosis.

A huge market need
Celiac disease has come to be known as a silent epidemic. It is a vastly undiagnosed disease, mainly due to the complexity of existing testing procedures. Left untreated, 35 per cent will develop osteoporosis, 30 per cent will develop other autoimmune disorders, such as diabetes type I and 20 per cent will suffer from recurrent anemia, even as it significantly increases the risks of abortion and intestinal lymphoma.

"The Simtomax test has effectively addressed the urgent market need for a rapid and simple test for Celiac disease," notes Frost & Sullivan Research Analyst Rasika Ramachandran. "With its unique features and functionality, the Simtomax test offers quick and uncomplicated diagnosis."

A state-of-the-art technology
So far, physicians have to draw about 10 milliliters of blood through a venous puncture and send the sample to specialised laboratories. Three different and separate analyses need to be performed to accurately diagnose Celiac disease. In some cases, physicians rely on an intestinal biopsy, a highly invasive procedure, to confirm laboratory results.

"In contrast, Augurix's innovative methodology performs all three analyses rapidly in a simple, one-step test," remarks Ramachandran. "It is significantly non-invasive, requiring only 25 microliters of a simple finger pinprick blood sample, identical to a glucose measurement or saliva sample."

The Simtomax test does not require confirmatory analyses. It works with whole blood, serum or plasma and sample collection is by finger pinprick. It provides clear and unambiguous results within 10 minutes, requires no training or equipment and can be stored at room temperature.

"Simtomax uses lateral flow technology to detect IgA and IgG (antibodies associated with gluten intolerance) against specific gliadin peptides," adds Ramachandran. "It also detects total IgA to identify all IgA deficient patients, which is currently a unique feature in the market place."

Simtomax already available in Switzerland and the EU
The Simtomax test has received the CE mark, allowing for product commercialization in the European Union. Augurix is currently launching its new product across the EU through dedicated distributors. It is already available in Switzerland, Italy and France. The Simtomax test is very well received, and offers a clear economic advantage over the traditional laboratory techniques.

The Product Differentiation Excellence Award is awarded to the company that has excelled in the following criteria: unique features/functionality, quality/complexity, matched to target markets needs and brand perception of the uniqueness of the product.

Frost & Sullivan Best Practices Awards recognise companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Augurix
Augurix (augurix.com) is a Swiss company that was incorporated in January 2007 in Geneva. Augurix develops, manufactures and markets disposable, pocket-size medical devices for rapid screening, diagnostic and monitoring of chronic conditions, with a strong focus on Celiac Disease. Augurix' patented technology enables seamless and rapid screening at the point of care, from whole blood, serum, plasma or saliva.

About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.

For more information, please contact:
Thierry Duvanel, CEO Augurix
E: thierry[.]augurix.com / T: +41(0)797 925 714

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Frost & Sullivan

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Frost & Sullivan Award Commends Augurix for its Unique Simtomax Test for Celiac Disease

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Frost & Sullivan | Press Room
Publisher Contact: Frost.com 
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Frost & Sullivan / Company Profile


Read Health/Surgery Most Recent Related Newswires:

Sustainable Alternatives to Polyvinylidene Chloride-coated Films Create Growth Opportunities & Transform the Food Packaging Markets in Western Europe
RIKEN Biofunctional Synthetic Chemistry Laboratory in Japan Has Developed A Way to Engineer Glycan Complexes Clusters of Sugar Chains
The Clinicians of Longs Peak Emergency Physicians Join US Acute Care Solutions
Frost & Sullivan Recognizes BroadReach for Improving the Health and Wellbeing of Underserved Populations
Silver Spring Emergency Physicians Join US Acute Care Solutions
Stress Light Therapy Launches Crowd-Funded Campaign on Indiegogo.com
The Float Space - Brisbane's First Float and Cryo Therapy Centre to Open This November
Thought Leaders Across the Healthcare Spectrum to Participate in Industry-Wide Survey
Frost & Sullivan Names Optum 2016 North America Company of the Year for Population Health Management
R-Pharm Produces Biological Drugs in Yaroslavl with GE Healthcare's FlexFactory™ Manufacturing Platform
GE to Invest €150 Million in Biopharmaceutical Manufacturing Campus in Cork, Ireland, and Establish Advanced Manufacturing Training Centre At NIBRT
Moriarty Physical Therapy of the Hudson Valley Expands with New Office in Lagrange, NY
Ultimate Medical Group Announces A New Regenerative Medicine Division
Dr. Amir Hanna Introduces New Medical Innovation Taking the Pain Out of Physical Therapy
Samitivej Children’s Hospital Transforms its Sukhumvit Campus

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  JobsWare.com





 
  ©2016 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)